<DOC>
	<DOCNO>NCT00868153</DOCNO>
	<brief_summary>This open-label , uncontrolled , multi-centre observational study analyse follow-up 1600 woman dysfunctional uterine bleeding ( idiopathic menorrhagia ) period one year.The patient evaluate four visit , begin insertion visit 3 , 6 12 month insertion .</brief_summary>
	<brief_title>Mirena Idiopathic Menorrhagia</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Woman diagnose idiopathic Menorrhagia accord assessment investigator accord international guideline . These woman also accept contraception time period Mirena situ . Age limit 3045 BMI= 1834 Signed inform consent Medical condition feature Mirena data sheet ( See Appendix 1 ) contraindicate use , list : Known suspected pregnancy ; current recurrent pelvic inflammatory disease ; infection lower genital tract ; postpartum endometritis ; septic abortion past three month ; cervicitis ; cervical dysplasia ; uterine cervical malignancy ; undiagnosed abnormal uterine bleeding ; congenital acquire abnormality uterus include fibroid distort uterine cavity ; condition associate increased susceptibility infection ; acute liver disease liver tumor ; know hypersensitivity constituent product . Nulliparity Consumption Iron , Antiprostaglandins , hormonal drug medication could effect bleed stop least 3 month first visit use course study . History diabetes mellitus , cardiovascular disease thyroid abnormalities Anticoagulation therapy Cancer history include breast cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>